SER Stock Analysis: Buy, Sell, or Hold?
SER - Serina Therapeutics, Inc.
$1.91
0.07 (3.80%)
▲
5d:
+0.53%
30d:
+11.05%
90d:
+30.82%
BUY
MODERATE Confidence
Analysis Updated: Jun 15, 2026 12:00 AM ET
Earnings: May 14, 2026
0d
Get Alerted When SER Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: SER shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: SER shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: SER is currently trading at $1.91, which is considered extended relative to its 30-day fair value range of $1.66 to $1.90.
Technical Outlook: Technically, SER is in a strong downtrend. Immediate support is located at $1.70, while resistance sits at $1.99. The stock is showing strong short-term momentum, up 3.8% recently.
Market Sentiment: SER has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $11.00 (+475.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, SER is in a strong downtrend. Immediate support is located at $1.70, while resistance sits at $1.99. The stock is showing strong short-term momentum, up 3.8% recently.
Market Sentiment: SER has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $11.00 (+475.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$1.66 -
$1.90
Company Quality Score
58/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
68.4%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.8%)
- BULLISH: Trading 475.9% below Wall St target ($11.00)
Trading Range Analysis
30-Day Trading Range
$1.66 -
$1.90
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$1.70
Resistance Level
$1.99
Current Trend
Strong Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.82
Wall Street Target
$11.00
(+475.9%)
Revenue Growth (YoY)
154.9%
Earnings Growth (YoY)
-43.5%
Share & Embed Analysis
Last updated: June 15, 2026 9:31 PM ET
Data refreshes hourly during market hours. Next update: 10:31 PM
Data refreshes hourly during market hours. Next update: 10:31 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SER showing a specific setup today?
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$102 | 58 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$105 | 56 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
|
BHVN
Biohaven Ltd. |
STRONG BUY
16 analysts |
$22 | 61 BUY |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$31 | 55 HOLD |
